FDA
-
-
-
-
-
-
-
Rhythm gets Japan approval for obesity drug Imcivree
-
-
-
-
-
-
-
Rhythm Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update
-
-
-
-
-
-
-
Rhythm Pharmaceuticals (RYTM) Announces Multiple New Data Presentations from MC4R Agonists
-
-
-
-
-
-
-
Rhythm Pharmaceuticals (RYTM) Reiterated at Market Outperform by Citizens
-
-
-
-
-
-
-
Rhythm Pharmaceuticals Announces New Data Presentations in Acquired Hypothalamic Obesity at Pediatric Endocrine Society
-
-
-
-
-
-
-
Leerink Partners on Rhythm Pharmaceuticals (RYTM): CHMP's positive opinion, language shows potential for broad EU labeling
-
-
-
-
-
-
-
Rhythm Pharmaceuticals EMANATE trial fails to meet primary endpoints
-
335,223 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


